|
|
(Millions of yen)
|
|
Fiscal year ended
March 31, 2024
|
Fiscal year ended
March 31, 2025
|
Cash flows from operating activities
|
|
|
Profit before income taxes
|
9,862
|
6,192
|
Depreciation
|
2,662
|
2,247
|
Impairment losses
|
-
|
300
|
Increase (decrease) in retirement benefit asset and liability
|
(5,262)
|
231
|
Interest and dividend income
|
(335)
|
(293)
|
Interest expenses
|
40
|
51
|
Foreign exchange losses (gains)
|
15
|
97
|
Share of loss (profit) of entities accounted for using equity method
|
41
|
53
|
Loss (gain) on sale and retirement of property, plant and equipment
|
2
|
0
|
Loss (gain) on sale of investment securities
|
(3,340)
|
(127)
|
Decrease (increase) in trade receivables
|
(370)
|
1,203
|
Decrease (increase) in inventories
|
(2,713)
|
(2,675)
|
Increase (decrease) in trade payables
|
1,494
|
339
|
Loss (gain) on step acquisitions
|
-
|
(1,257)
|
Other, net
|
626
|
(180)
|
Subtotal
|
2,724
|
6,183
|
Interest and dividends received
|
414
|
379
|
Interest paid
|
(41)
|
(51)
|
Income taxes paid
|
(1,611)
|
(4,026)
|
Net cash provided by (used in) operating activities
|
1,486
|
2,485
|
Cash flows from investing activities
|
|
|
Proceeds from redemption of securities
|
400
|
500
|
Purchase of securities
|
(500)
|
-
|
Purchase of property, plant and equipment
|
(1,320)
|
(2,960)
|
Proceeds from sale of property, plant and equipment
|
1
|
0
|
Purchase of intangible assets
|
(133)
|
(602)
|
Purchase of investment securities
|
(352)
|
-
|
Proceeds from sale of investment securities
|
4,230
|
252
|
Purchase of shares of subsidiaries and associates
|
(1,464)
|
-
|
Purchase of shares of subsidiaries resulting in change in scope of
consolidation
|
-
|
(2,189)
|
Other, net
|
845
|
(1,125)
|
Net cash provided by (used in) investing activities
|
1,706
|
(6,124)
|
Cash flows from financing activities
|
|
|
Proceeds from long-term borrowings
|
-
|
3,000
|
Repayments of long-term borrowings
|
(3,138)
|
(4,680)
|
Net decrease (increase) in treasury shares
|
9
|
(0)
|
Dividends paid
|
(792)
|
(1,275)
|
Other, net
|
(22)
|
-
|
Net cash provided by (used in) financing activities
|
(3,943)
|
(2,956)
|
Effect of exchange rate change on cash and cash equivalents
|
(15)
|
(97)
|
Net increase (decrease) in cash and cash equivalents
|
(766)
|
(6,692)
|
Cash and cash equivalents at beginning of period
|
17,505
|
16,738
|
Increase in cash and cash equivalents resulting from inclusion of
subsidiaries in consolidation
|
-
|
556
|
Cash and cash equivalents at end of period
|
16,738
|
10,603
|